bioRxiv Science⌕ Search

Biology subjects

Tan, J.

Publications and source records attributed to Tan, J..

At least 19 recordsLinked to original sources

Aberrant cortical reorganization and astrogliosis underlie memory deficit post-traumatic brain injury: a longitudinal multiscale multimodal study

Integrating high-dimensional neuroimaging data across spatial scales remains a fundamental bottleneck in quantitative neuroscience. Here, we apply emerging analytical techniques including functional connectome gradient mapping and 3D segmentation of whole-brain cellular resolution microscopy data in a mouse model of traumatic brain injury. At the macroscale, longitudinal functional MRI revealed a transition from frontal hyperconnectivity to hippocampal hypoconnectivity and unimodal-transmodal gradient contraction indicating network dedifferentiation. At the cellular scale, deep-learning based segmentation of whole-brain light-sheet fluorescence microscopy volumes quantified regional astrogliosis, neuronal hyperactivity, and single-axon loss undetected by standard diffusion MRI. Multiscale multimodal data integration not only identified quantitative biomarkers predictive of memory performance post-injury but also enabled validation of in vivo modalities against more sensitive ex vivo histology. This study demonstrates a framework for probing complex multi-network cognitive functions and neurological disorders of network dysfunction.

neuroscience↗

Combining an autoactivated cGAS mutant with membrane-tethered IL-12 via mRNA lipid nanoparticles promotes systemic tumor control

Local tumor therapies rarely induce systemic immunity capable of controlling metastatic disease. Here, we engineer an mRNA lipid nanoparticle (LNP) platform to coordinate innate immune sensing and T cell activation in situ through co-delivery of an autoactivated cyclic GMP-AMP synthase mutant (cGASR241E) and membrane-tethered IL-12 (IL-12TM). cGASR241E mRNA LNPs autonomously generated cyclic GMP-AMP in vivo, activating host STING signaling and initiating antitumor responses. Co-administration with IL-12TM mRNA LNPs promoted localized cytokine production, reduced regulatory T cells, and restored effector function in tumor-infiltrating T cells. This combination elicited systemic antitumor immunity and suppressed distal tumors across multiple mouse models. The therapeutic efficacy required CD8+ T cells and IFNg; signaling in host, supporting a model in which innate DNA sensing is coupled to IL-12-mediated T cell functional reinforcement. In addition, the combination enhanced responsiveness to PD-L1 blockade. Together, these findings establish a clinically translatable strategy to integrate cGAS-STING activation with cytokine-driven T cell programming to drive systemic tumor control.

cancer biology↗

Achieving near single-molecule sensitivity in separation-free protein detection using engineered kinetic proofreading

Unlike nucleic acids, proteins cannot be directly amplified. Ultrasensitive detection must therefore couple efficient analyte-to-signal conversion with strong suppression of target-independent background. Consistently detecting ~100 molecules (below which Poisson sampling noise alone causes CV to exceed 10%) across protein targets in a format as scalable and accessible as PCR remains unsolved. Separation-based ultrasensitive immunoassays require target binding stable enough to survive stringent washing and are therefore constrained by wash-induced signal loss and, more fundamentally, the relative scarcity of exceptionally tight binders. Performance consequently varies across targets; detection limits below 1,000 molecules remain rare. Conventional separation-free proximity assays avoid washing but incur background from random probe collisions, with reported detection limits frequently exceeding 100,000 molecules. Here we introduce Successive Proximity Extension Amplification Reaction (SPEAR), a separation-free architecture in which autonomous engineered DNA nanodevices emulate biological kinetic proofreading. Two successive irreversible proximity-extension steps compound discrimination between analyte-dependent and background reactions, suppressing spurious signals while preserving efficient analyte-to-signal conversion. This design reduces reliance on high-affinity binders and enables sub-fM detection from 1 uL samples through simple 3-step mixing followed by standard qPCR readout. Across 11 biomarkers tested, SPEAR consistently achieved sub-100-molecule detection limits. Where compared, it outperformed ultrasensitive separation-based platforms, analytically and clinically, including for low-abundance Alzheimer's disease biomarkers. SPEAR also precisely quantified SARS-CoV-2 neutralizing antibody titers from finger-prick dried blood spots, concordant with the cell-based reference assay on venous blood. It detected a distinct mixed phosphorylation state of Tau, and targeting this state resolved previously observed capillary-venous discordance and improved amyloid-status discrimination. These results establish engineered autonomous successive molecular discrimination as a practical strategy for near-single-molecule protein detection, extending the sensitivity, scalability and accessibility of PCR-based testing to non-amplifiable analytes.

bioengineering↗

High-order enhancer hubs buffer allelic regulatory variation through kinetic compensation

Diploid genomes carry millions of heterozygous variants in cis-regulatory DNA, yet most genes produce similar RNA output from two parental alleles. How this balance is maintained is unclear. We developed Nanopore-HiChIP, a long-read method that maps high-order enhancer hubs on each haplotype. Over half of these enhancer hubs differ in chromatin architecture and transcription-factor occupancy between homologous chromosomes, but their target genes show substantially lower rates of allele-specific expression than genes lacking hub regulation. Single-cell kinetic modeling shows that burst frequency and burst size change in opposite directions, thereby preserving balanced transcriptional output. This hub-mediated kinetic buffering is enriched at haploinsufficient genes and coincides with smaller effects of expression quantitative trait loci. Enhancer hubs therefore absorb allelic regulatory variation through kinetic compensation, protecting dosage-sensitive transcription.

genomics↗

MEG Signatures of Differences in Auditory Cortex Responses to Trigger versus Non-Trigger Sounds in Misophonia

Misophonia is characterized by intense emotional and physiological reactions to specific trigger sounds that may vary across individuals. Despite greater recognition and increased research, the neural mechanisms underlying misophonia are still poorly understood. Using magnetoencephalography (MEG) with millisecond temporal resolution, we examined auditory cortex responses to trigger versus non-trigger sounds in 23 individuals (ages 14 - 32 years) that met criteria for misophonia on a screening assessment. We found that in the right hemisphere, trigger sounds elicited significantly smaller evoked responses, lower power of evoked alpha-band oscillations, and stronger alpha-gamma cross-frequency phase-amplitude coupling, compared to non-trigger sounds. We also found that evoked responses and power correlated with behaviorally assessed extent of misophonia symptoms. These findings support the idea that misophonia is characterized at least in part by altered neurophysiological processing of auditory trigger stimuli early in auditory cortex hierarchy. Our results provide novel insight into the neural basis of misophonia, and underscore the importance of examining brain activity even at the earliest levels of the cortical hierarchy, especially with high spatio-temporal resolution.

neuroscience↗

Chromosomal mutational signatures of DNA damaging agents at single cell resolution

The chromosomal-scale mutational spectrum of small molecules that interact with DNA has been hard to study at scale, as mutational events are distributed in location and occur in parallel in different cells. Here, we present a framework that pairs phylogenetic ancestry reconstruction with mutational signature decomposition to characterise recent, cell-private copy number alteration (CNA) mutational patterns at single-cell resolution. We used this framework to characterise the cell-wise mutational spectrum of contemporaneous CNAs generated by double-strand-break-inducing chemotherapeutic drugs. We demonstrate that platinum salts, G-quadruplex stabilizers and topoisomerase II inhibitors, although mechanistically distinct, converge on a mutational signature dominated by telomere-bounded copy-number gains and losses. This signature is observed in different genetic backgrounds and in vivo in drug-treated patient-derived xenografts. We also observe a high rate of endogenous telomere-bounded mutational foreground in BRCA1 deficient cells. We show that the single cell genome derived signature exposures are drug dose-dependent, and use this to identify the decay of mutational load after drug withdrawal. We observe that both cisplatin and a G4 binder molecule (CX5461) exhibit foreground mutational signature persistence for at least 3 weeks after drug withdrawal, suggesting that residual effects of exposure may last longer than anticipated. Finally, extending the framework to serially drug-treated patient-derived xenograft (PDX) models, we show that telomere-bounded CNA signature exposure is associated with tumoural response to drug, consistent with loss of mutational activity on the genome after acquired resistance emerges. Together, our results show that our framework applied on scWGS identifies contemporaneous chromosomal mutation patterns induced by small molecules in human tissues.

cancer biology↗

LTBP isoforms differentially encode TGF-β spatial localization and activation

TGF-{beta} signals through a conserved pathway yet produces diverse outcomes, pointing to regulatory mechanisms upstream of receptor engagement. A family of four latent TGF-{beta} binding proteins (LTBPs) tether pro-TGF-{beta}s and control their localization and activation, but how distinct LTBPs contribute to this regulation is unclear. Here we combine cryo-electron microscopy with functional assays to dissect LTBP-pro-TGF-{beta} interactions. We resolve the LTBP-1/pro-TGF-{beta}1 and LTBP-3/pro-TGF-{beta}3 complex structures, revealing a conserved yet plastic hydrophobic binding interface, and systematically map key residues across all four LTBP and three pro-TGF-{beta} subtypes that determine binding specificity and affinity. Unexpectedly, LTBP-2, previously thought incapable of TGF-{beta} binding, engages pro-TGF-{beta}1 through a covalent linkage via its 16th EGF-like domain, providing a mechanistic link between LTBP-2 function and TGF-{beta} signaling. Beyond tethering, LTBP-3 shifts pro-TGF-{beta}3 from spontaneous activation toward integrin dependence, establishing LTPBs as dynamic modulators that dictate not only where but also how TGF-{beta} is unleashed. Collectively, these findings establish that LTBPs are not redundant ECM scaffolds but a family of functionally distinct regulators that differentially encode TGF-{beta} spatial localization and activation, with implications for isoform-selective therapeutic strategies.

biochemistry↗

Short-term dietary change rapidly remodels microbial community assemblages and reprogrammed systemic immune phenotypes

Diet is a major determinant of the gut microbiome and immune homeostasis, yet the extent to which short-term dietary interventions can remodel established microbial communities and reprogramme immune phenotypes following long-term western diet consumption remains poorly understood. Here, we investigated temporal dynamics of the gut microbiome, microbial metabolites, intestinal barrier function and local and systemic immune responses following diet switching. Mice were fed either a standard chow or a western diet for 8 weeks before remaining on these diets or switching to the alternate diet for 2 or 4 weeks. Long term consumption of chow and western diets resulted in distinct gut microbial communities and differences in intestinal permeability. Diet switching rapidly remodelled microbial community structure within two weeks, with substantial bidirectional changes in community composition. Despite these changes, the relative abundance of several taxa remained influenced by prior dietary exposure. In contrast, faecal SCFA profiles remained largely associated with long-term diet, indicating that microbial metabolic outputs were altered more slowly than microbial community composition. Mass cytometry revealed progressive remodelling of local (MLN) and systemic (PBMC and spleen) immune responses following dietary switching. Activation-associated immune phenotypes, including Ki67+ and PD-1+ B and T cells, inflammatory monocytes and ROR{gamma}t+ regulatory T cells, rapidly responded to diet switching, whereas overall B cells, regulatory T cells and effector memory T cells retained signatures of long-term dietary exposure. Together, these findings demonstrate distinct temporal dynamics across the diet-microbiome-immune axis, whereby gut microbial composition and immune activation states remain highly plastic, while microbial metabolic outputs and several memory and regulatory immune phenotypes exhibit persistent dietary imprinting. These findings highlight the potential utility of short-term dietary interventions to modulate host-microbiome interactions and immune homeostasis.

immunology↗

Joint analysis of multiply perturbed cells improves statistical power and cost efficiency in Perturb-seq

Perturb-seq measures transcriptomic responses to genetic perturbations at scale, but conventional designs that enrich for one guide RNA per cell remain resource-intensive. Standard analyses discard cells carrying multiple guides, further limiting the usable yield from each experiment. Here, we characterize how incorporating these guide multiplets affects signal recovery, information loss, and cost reduction. At the highest guide burden, cells showed increased stress and suppressed cell-cycle progression. We develop PerturbMatch, a scalable statistical framework to analyze guide multiplets. Among different classes of guide multiplets, doublets and triplets recovered perturbation responses more accurately than higher-order multiplets. Across three 5000-gene Perturb-seq screens with increasing guide loading, per-cell costs decreased by up to 81% while information loss remained within 1.5-fold of the loss observed between technical replicates. In existing genome-wide Perturb-seq data, incorporating previously discarded guide multiplets increased usable cell numbers and improved statistical power. Compared with a singlet holdout set, adding guide multiplets moved signal recovery closer to the theoretical expected reproducibility. Overall, we recommend a design that intentionally includes single-guide cells, guide doublets, and guide triplets to improve cost efficiency while preserving signal recovery.

genomics↗

Cortical Excitation-Inhibition Balance in Autism Varies by Brain Region and Age

Autism spectrum disorder (ASD) is characterized by differences in social communication, interaction, and restricted and repetitive behaviors. The hypothesis that ASD involves altered cortical excitation-inhibition (EI) balance has been extensively investigated, yet evidence remains mixed, partly because EI balance changes substantially during typical maturation. We used resting-state magnetoencephalography (MEG) to examine developmental trajectories of cortical EI alterations with regional specificity in a large cross-sectional cohort (N = 172; 92 typically developing, 80 ASD; ages 6-32). Functional EI (fEI), derived from critical brain dynamics, was estimated across 500 cortical parcellations. Group-averaged fEI maps revealed broadly similar large-scale topographic patterns across groups. Age-stratified analyses revealed increased global fEI in childhood and decreased fEI in adolescence in ASD, with no evidence of a group difference in adulthood. Parcel-wise regressions identified a significant main effect of diagnosis in right dorsolateral prefrontal cortex, where typically developing individuals showed higher fEI across all ages. A significant group-by-age interaction in left inferior parietal cortex indicated diverging developmental trajectories. Finally, fEI in paracentral and precuneus regions was associated with the magnitude of ASD symptoms. These findings indicate that EI imbalance in ASD is neither globally distributed nor static, but expressed through regionally and developmentally specific differences, with relevance for ASD heterogeneity.

neuroscience↗

Candida albicans reprograms host inosine metabolism to drive immunosuppressive macrophage polarization and gastric cancer carcinogenesis

Gastric cancer (GC) is strongly associated with changes in the gastric microbiome. However, the direct contribution of individual pathogenic species to tumor initiation and progression remains poorly defined. Here, we identified Candida albicans (C. albicans), a fungus that ranks as the most significantly enriched taxon in GC tissues, can directly promote gastric carcinogenesis. We found that when C. albicans alone was colonized into the gastric mucosa of mice, it induced the complete sequence of GC-associated preneoplastic lesions, including chronic gastritis, mucinous metaplasia, and atypical hyperplasia, with 16% of colonized animals progressing to low-grade intraepithelial dysplasia. In K19-C2mE transgenic mice, a model of spontaneous GC formation, infection with C. albicans significantly accelerated GC formation, with synergistic effects observed upon co-infection with the well-known gastric carcinogen, Helicobacter pylori. Mechanistically, C. albicans upregulated inosine levels in both gastric tissues and circulation. This inosine promoted polarization of macrophages toward an M2-like phenotype by activating the adenosine A2a receptor (A2aR), creats an immunosuppressive microenvironment that protects GC cells from the tumoricidal effects of anti-tumor immunity. Depletion of M2 macrophages or pharmacological inhibition of A2aR attenuated C. albicans-mediated tumorigenesis. Clinically, elevated inosine levels correlated with prior C. albicans exposure and poorer outcomes of GC patients. Our findings establish C. albicans as a direct pro-tumorigenic pathogen in GC and highlight the inosine-A2aR-M2 macrophage axis as a promising target for therapeutic intervention.

cancer biology↗

SMEW: An interactive multi-scale toolkit for cross-condition and network-based analysis of spatial metabolomics data

Spatial metabolomics, measured through mass spectrometry imaging (MSI), provides high-throughput, spatially resolved information on metabolite distributions within tissues, including endogenous metabolites and exogenous compounds. This offers a direct readout of cellular biochemical activity and phenotypes, not fully captured by transcriptomics or proteomic profiling. However, inferring biologically meaningful patterns from noisy, high-dimensional MSI data, particularly across multiple samples and complex experimental designs, remains challenging, and often requires substantial programming expertise. Here we introduce SMEW (Spatial Metabolomics Enhanced Workflow), a flexible, interactive and shareable Shiny-based platform designed to enable code-free downstream analysis of spatial metabolomics MSI data. SMEW provides a unified environment for hierarchical analysis across bulk-, region- and pixel-level resolutions, allowing comparisons between experimental conditions like disease or treatment groups while highlighting coherent metabolic patterns and linking these patterns to biological pathways. The workflow leverages local spatial covariation to robustly summarise MSI data through dimensionality reduction, clustering and identification of spatially variable metabolites. In addition, metabolite co-localisation and covariation network analysis, together with spatially resolved pathway enrichment facilitate the biological interpretation of cross-condition datasets within a single integrated interface. SMEW is applicable across MSI technologies and mass resolutions, as illustrated through case studies on DESI and MALDI-ToF datasets from lung, liver, and kidney. By complementing existing MSI processing and visualisation tools with an accessible, multi-sample, and biologically interpretable analysis framework, SMEW enables functional, flexible, rigorous and intuitive exploration of spatial metabolomics datasets. Graphical Abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=84 SRC="FIGDIR/small/721059v1_ufig1.gif" ALT="Figure 1"> View larger version (29K): org.highwire.dtl.DTLVardef@1e2abaeorg.highwire.dtl.DTLVardef@753ee9org.highwire.dtl.DTLVardef@1756fc1org.highwire.dtl.DTLVardef@fbedc7_HPS_FORMAT_FIGEXP M_FIG C_FIG Key PointsO_LISMEW provides a flexible, interactive and shareable Shiny-based platform designed to enable code-free downstream analysis of spatial metabolomics MSI data C_LIO_LIThe SMEW framework enables hierarchical analysis at bulk-, region- and pixel levels within a unified framework without relying on extensive programming expertise C_LIO_LIThe pipeline integrates spatially aware clustering, pathway analysis and identification of metabolite co-localisation modules C_LIO_LIThe workflow facilitates flexible comparison of multi-sample experimental conditions through multivariate modelling, differential testing and covariation networks to study treatment- and disease-associated metabolite dynamics C_LIO_LISMEW has been applied to interrogate diverse biological questions, including characterising disease-associated remodelling in a mouse bleomycin model of pulmonary fibrosis, exploring the therapeutic index of antisense oligonucleotides in the liver and assessing metabolic heterogeneity in a small molecule-treated mouse renal tumour model C_LI

bioinformatics↗

The UV potentiated mutational signature of clinical stage G-quadruplex binder CX5461.

Drug-related UVA-induced photoreactions have been reported for several therapeutic compounds, including fluoroquinolones. CX5461 is a clinically relevant quinolone-derived anti-cancer small molecule with documented UVA-sensitising activity. Here we compared, by bulk and clonal whole genome sequencing (WGS) under light-protected conditions, the mutational signatures in human retinal pigment epithelial cells (RPE1) exposed to UVA, CX5461, or co-exposed to UVA and CX5461. Treatment with CX5461 or UVA alone resulted in a low SNV burden and background-like mutational profiles. In contrast, bulk sequencing of human cells co-exposed to UVA and CX5461 had a markedly higher SNV burden characterized by T>A and T>C substitutions. Furthermore, single-cell clonal expansion and sequencing of CX5461 alone, UVA alone or CX5461+UVA treatments confirmed that the pattern was only observed when cells were exposed to both UVA and CX5461. The CX5461+UVA-associated SNV signature we report arises only when CX5461-treated cells are exposed to UVA, and is not observed when CX5461-treated cells are shielded from light. We do not observe strong single base mutagenic activity of CX5461 alone, under light protected conditions. Our data emphasise the need for appropriate controls and light-exposure precautions when studying base mutagenesis activity of known photosensitiser molecules.

cancer biology↗

Inhibition of miR-1307 Reverses Resistance to Cisplatin in Drug-Resistant Oral Squamous Cell Carcinoma

BackgroundChemo-resistance remains a major clinical challenge in Oral Squamous Cell Carcinoma (OSCC), attributed to the intrinsically resistant cells. Although tumour-derived extracellular vesicles (EVs) have been implicated in cell-cell communication, their role in propagating chemo-resistance remains poorly defined. This study aims to identify salivary EV-associated miRNAs capable of predicting chemoresistance and to delineate the role of miR-1307-5p in modulating CSC-driven therapeutic refractoriness. MethodsSalivary EV-derived expression profile of miR-1307-5p was assessed by qPCR in chemo resistant OSCC patients and further validated in TCGA small RNA sequencing datasets. Expression was validated by qPCR and correlated with clinicopathological outcomes. Functional assays including cell-cycle analysis, apoptosis, migration/invasion, 3D spheroids, angiogenesis, and CAM assays were performed in miR-1307-5p inhibited CD44 CSC subpopulation compared to its vehicular control. Transcriptomic profiling cross-referencing with TCGA was conducted to identify potential novel targets of miR-1307-5p. Chemo-sensitisation was assessed by treating the knockdown chemo resistant cells with low dose cisplatin and validating it using in-vitro functional assays and orthotopic xenograft model. ResultsmiR-1307-5p was significantly elevated in salivary EVs of chemo resistant OSCC patients and correlated with poor overall survival (p = 0.03). The miRNA was markedly enriched in endogenously resistant CD44 CSCs. Silencing of miR-1307-5p induced G2/M arrest, triggered apoptosis, impaired invasion, and reduced angiogenesis both in-vitro and in ex-vivo assays. Transcriptomic profiling, TCGA validation, and integrative pathway analysis identified key oncogenic hubs which converge on PI3K-AKT, MAPK/ERK, and YAP signalling pathways governing EMT. Inhibition of miR-1307-5p restored cisplatin sensitivity in resistant CSCs, with low-dose cisplatin producing substantial tumour suppression in-vitro and in-vivo. Reduced CD44 expression in xenograft models confirmed CSC reprogramming. EVs from anti-miR-treated cells confer chemo sensitisation upon uptake by resistant CSCs. Xenograft models substantiated that EVs can initiate tumour formation and that EV-mediated delivery of anti-miR-1307-5p drives significant tumour regression. ConclusionThis study identifies salivary EV-derived miR-1307-5p as a clinically relevant biomarker of chemoresistance in OSCC and reveals its mechanistic role in sustaining CSC-driven therapeutic failure. Targeting miR-1307-5p offers a promising avenue for restoring cisplatin sensitivity and developing exosome-based therapeutic strategies. Graphical Abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=150 SRC="FIGDIR/small/709730v1_ufig1.gif" ALT="Figure 1"> View larger version (38K): org.highwire.dtl.DTLVardef@19f88e0org.highwire.dtl.DTLVardef@d36b95org.highwire.dtl.DTLVardef@3c2579org.highwire.dtl.DTLVardef@c04ef5_HPS_FORMAT_FIGEXP M_FIG C_FIG

cancer biology↗

SnakeHichipTF reveals transcription factor logic underlying enhancer-promoter wiring in the human brain

Enhancer-promoter interactions are a central feature of gene regulation, yet the regulatory logic that governs their selective formation in complex tissues remains poorly understood. To address this gap, we developed SnakeHichipTF, a reproducible and scalable framework that integrates multi-engine HiChIP analysis with AI-based footprinting to decode the transcription factor (TF) logic underlying enhancer-promoter wiring. Applying SnakeHichipTF to HiChIP datasets from the human Middle Frontal Gyrus (MFG) and Substantia Nigra (SN), we identified distinct region-biased enhancer interactions associated with differential gene expression. MFG-biased interactions were enriched for cognitive and psychiatric associated GWAS traits, whereas SN-biased interactions preferentially intersected lipid and metabolic trait architectures. Integration of TF footprinting revealed that these region-biased interaction networks are governed by distinct TF programs: MFG-biased interactions preferentially recruited TFs linked to neuronal signaling and transcriptional activation, whereas SN-biased interactions were associated with metabolic and stress-responsive regulators. Interestingly, MFG-biased regulatory interactions were significantly enriched for Human Accelerated Regions (HARs), and HAR-associated genes showed elevated expression in humans relative to non-human primates, indicating that cortical enhancer wiring is embedded within evolutionarily modified regulatory elements. Together, by linking 3D chromatin architecture, TF logic, genetic risk, and evolutionary regulatory elements, SnakeHichipTF provides a general framework for dissecting the mechanistic basis of spatial gene regulation.

genomics↗

Assessing Brain-Behaviour Coupling in Non-invasive Brain Stimulation Using Reliable Change Indices: Evidence from pre-Supplementary Motor Area - right Inferior Frontal Gyrus transcranial Alternating Current Stimulation

Non-invasive brain stimulation (NiBS) studies frequently report exploratory correlations between individual-level changes in neurophysiological and behavioural measures. However, these analyses are typically underpowered and rely on ratio-based change scores with known statistical limitations. We addressed these limitations by pooling individual data from three independent studies (total N = 69), providing adequate power to detect small-to-medium effects. All studies applied 20 Hz transcranial alternating current stimulation (tACS) targeting the pre-supplementary motor area (preSMA) and right inferior frontal gyrus (rIFG), regions central to inhibitory control. Changes in preSMA-rIFG connectivity measured with EEG imaginary coherence (ImCoh) and response inhibition (stop-signal reaction time, SSRT) were quantified using reliable change indices (RCI), which were z-standardised within studies to enable pooled mixed-effects regression. No meaningful association was found between tACS-induced ImCoh change and SSRT change (r = .013, marginal R{superscript 2} = .004), with project-wise correlations that were small, non-significant, and inconsistent in direction. Sensitivity analysis using ratio-based change scores converged on the same null result (r = .014), though ratio scores showed severe distributional violations relative to the approximately normal RCI distributions, supporting the methodological case for RCI on statistical grounds. These results provide no support for a systematic individual-level brain-behaviour coupling between preSMA-rIFG connectivity and response inhibition following 20 Hz tACS, and suggest that any true effect is likely to be small. The present work offers a methodological benchmark for quantifying individual-level brain-behaviour coupling in NiBS research, and highlights the need for more sensitive neural markers and adequately powered design.

neuroscience↗

Comprehensive characterization of Plasmodium vivax antigens using a high-density peptide array

Plasmodium vivax is the second most prevalent Plasmodium species, with 2.5 billion people at risk of infection worldwide and around 10 million cases of clinical vivax malaria every year. Despite the clinical importance of this pathogen, very little is known about the P. vivax proteins recognized by the host immune system, which hinders our ability to select vaccine candidates or develop efficient serological markers. To comprehensively characterize immunogenic P. vivax proteins, we designed a high-density peptide array containing 4.2 million peptides covering the entire protein sequence of all P. vivax genes and analyzed antibody responses of infected and malaria-naive individuals. We identified a total of 283 proteins that are commonly immunogenic in symptomatic individuals. These proteins included most proteins known to be involved in erythrocyte invasion, a putative new invasion protein, several nucleoporins, and many uncharacterized proteins that should be further investigated for their roles during blood-stage infections. These analyses also revealed a unique pattern of antibody response against PIR proteins in asymptomatic individuals, that could be associated with protection against clinical vivax malaria. Overall, these data provide an agnostic and comprehensive perspective on immunogenic P. vivax proteins and constitute an important resource for the malaria community to develop new tools for better detecting and eliminating this important human pathogen.

microbiology↗

Betrayal is worse than loss during cooperation

Cooperative behavior is a cornerstone of human interaction. Although both "betrayal aversion" (the affective cost of being betrayed) and "loss aversion" (the financial detriment incurred from betrayal) are established determinants of cooperative behavior, their relative potency remains undetermined. Here, we investigated these effects by integrating computational modeling and event-related potential (ERP) techniques. In two tasks involving risk and cooperation, participants decided whether to take financial risks or to cooperate under possible betrayal. Our results showed that betrayal aversion had a stronger effect on reducing cooperation compared to loss aversion. Furthermore, ERP data demonstrated sequential processing: betrayal was encoded early in decision-making, reflected by increased P3 with weaker betrayal aversion, whereas loss aversion manifested later, marked by increased LPP. By dissociating the contributions of betrayal and loss, our finding provides novel insights into the cognitive and neural mechanisms underlying cooperative behavior.

neuroscience↗